This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Aier Eye-Zhongshixin deal published by SAMR for simple case review

( December 26, 2019, 04:57 GMT | Official Statement) -- MLex Summary: A plan by China's Aier Eye Hospital Group to fully acquire Tianjin Zhongshixin Enterprise Management, which owns companies that are engaged in eye-care services, has been published for a simple case review by the Antimonopoly Bureau of China’s State Administration for Market Regulation. The period for public comment runs from Dec. 26 through Jan. 4.爱尔眼科医院集团股份有限公司收购天津中视信企业管理有限公司股权案...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents